HEADER VIRAL PROTEIN 18-SEP-20 7D3C TITLE THE NEWLY EMERGED SARS-LIKE CORONAVIRUS HCOV-EMC ALSO HAS AN TITLE 2 "ACHILLES' HEEL": CURRENT EFFECTIVE INHIBITOR TARGETING A 3C-LIKE TITLE 3 PROTEASE CAVEAT 7D3C PJE C 5 HAS WRONG CHIRALITY AT ATOM C26 PJE E 5 HAS WRONG CAVEAT 2 7D3C CHIRALITY AT ATOM C26 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: NSP5, GROWTH FACTOR-LIKE PEPTIDE,LEADER PROTEIN,NON- COMPND 5 STRUCTURAL PROTEIN 10,NON-STRUCTURAL PROTEIN 2,NON-STRUCTURAL PROTEIN COMPND 6 3,NON-STRUCTURAL PROTEIN 4,NON-STRUCTURAL PROTEIN 6,NON-STRUCTURAL COMPND 7 PROTEIN 7,NON-STRUCTURAL PROTEIN 8,NON-STRUCTURAL PROTEIN 9,PAPAIN- COMPND 8 LIKE PROTEINASE,P65 HOMOLOG; COMPND 9 EC: 3.4.19.12,3.4.22.69; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- COMPND 13 ((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3- COMPND 14 YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE; COMPND 15 CHAIN: C, E; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MIDDLE EAST RESPIRATORY SYNDROME-RELATED SOURCE 3 CORONAVIRUS; SOURCE 4 ORGANISM_COMMON: MERS-COV; SOURCE 5 ORGANISM_TAXID: 1335626; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS MERS-COV, NSP5, N3, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR L.YAN,Z.REN REVDAT 3 29-NOV-23 7D3C 1 REMARK REVDAT 2 15-NOV-23 7D3C 1 LINK ATOM REVDAT 1 03-NOV-21 7D3C 0 JRNL AUTH Z.REN,L.YAN,N.ZHANG,Y.GUO,C.YANG,Z.LOU,Z.RAO JRNL TITL THE NEWLY EMERGED SARS-LIKE CORONAVIRUS HCOV-EMC ALSO HAS AN JRNL TITL 2 "ACHILLES' HEEL": CURRENT EFFECTIVE INHIBITOR TARGETING A JRNL TITL 3 3C-LIKE PROTEASE JRNL REF PROTEIN CELL V. 4 248 2013 JRNL REFN ESSN 1674-8018 JRNL PMID 23549610 JRNL DOI 10.1007/S13238-013-2841-3 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.7.1_743 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.22 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 39516 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 2006 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 5.5000 - 5.2951 0.99 2842 134 0.1905 0.2108 REMARK 3 2 5.2951 - 4.2058 1.00 2715 155 0.1721 0.2103 REMARK 3 3 4.2058 - 3.6750 1.00 2723 146 0.1994 0.2734 REMARK 3 4 3.6750 - 3.3394 1.00 2661 160 0.2215 0.2756 REMARK 3 5 3.3394 - 3.1002 1.00 2693 137 0.2266 0.2738 REMARK 3 6 3.1002 - 2.9176 1.00 2667 141 0.2487 0.3194 REMARK 3 7 2.9176 - 2.7716 1.00 2670 140 0.2467 0.3392 REMARK 3 8 2.7716 - 2.6510 1.00 2664 142 0.2669 0.2898 REMARK 3 9 2.6510 - 2.5490 1.00 2674 127 0.2499 0.3610 REMARK 3 10 2.5490 - 2.4610 1.00 2640 137 0.2522 0.3408 REMARK 3 11 2.4610 - 2.3841 1.00 2648 153 0.2580 0.3292 REMARK 3 12 2.3841 - 2.3160 1.00 2632 143 0.2628 0.3542 REMARK 3 13 2.3160 - 2.2550 1.00 2641 146 0.2908 0.3311 REMARK 3 14 2.2550 - 2.2000 1.00 2640 145 0.2930 0.3720 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 45.49 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.640 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.280 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 10.02990 REMARK 3 B22 (A**2) : -12.43800 REMARK 3 B33 (A**2) : 2.40810 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4794 REMARK 3 ANGLE : 1.309 6522 REMARK 3 CHIRALITY : 0.084 744 REMARK 3 PLANARITY : 0.005 826 REMARK 3 DIHEDRAL : 16.893 1656 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7D3C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1300018665. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9785 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 240588 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.670 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 1UJ1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM TRIMETHYLAMINE N-OXIDE REMARK 280 DIHYDRATE, 0.02 M CADMIUM CHLORIDE HYDRATE, 100 MM TRIS-HCL (PH REMARK 280 8.5), AND 16% W/V POLYETHYLENE GLYCOL MONOMETHYL ETHER 2000, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 39.81000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.50750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.61150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.50750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.81000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.61150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24730 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A, C, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)- REMARK 400 4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL) REMARK 400 -L-LEUCINAMIDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R, REMARK 400 2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL] REMARK 400 METHYL}BUT-2-ENYL)-L-LEUCINAMIDE REMARK 400 CHAIN: C, E REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE B 72 REMARK 465 GLY B 73 REMARK 465 ALA B 74 REMARK 465 PRO B 75 REMARK 465 VAL B 304 REMARK 465 MET B 305 REMARK 465 GLN B 306 REMARK 465 VAL A 304 REMARK 465 MET A 305 REMARK 465 GLN A 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 401 O HOH A 474 1.76 REMARK 500 N SER B 1 O HOH B 401 1.78 REMARK 500 N SER B 1 O HOH B 402 1.86 REMARK 500 O VAL A 303 O HOH A 401 2.00 REMARK 500 NE2 GLN A 86 O HOH A 402 2.12 REMARK 500 OH TYR B 153 O HOH B 403 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL E 3 C LEU E 4 N 0.141 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 283 N - CA - C ANGL. DEV. = -15.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 33 -118.92 41.64 REMARK 500 ASP B 51 92.25 -167.27 REMARK 500 ASN B 53 77.32 58.26 REMARK 500 ALA B 171 166.99 179.94 REMARK 500 ASN B 172 125.45 -39.19 REMARK 500 ALA B 187 -0.17 60.94 REMARK 500 GLN B 192 35.79 -87.17 REMARK 500 ASP A 33 -120.47 54.82 REMARK 500 ASP A 51 71.16 -172.23 REMARK 500 LEU A 282 65.47 39.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR B 185 GLY B 186 -72.44 REMARK 500 LEU A 282 GLY A 283 -34.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 494 DISTANCE = 6.63 ANGSTROMS DBREF1 7D3C B 1 306 UNP A0A0D3MU45_MERS DBREF2 7D3C B A0A0D3MU45 3158 3463 DBREF1 7D3C A 1 306 UNP A0A0D3MU45_MERS DBREF2 7D3C A A0A0D3MU45 3158 3463 DBREF 7D3C C 1 6 PDB 7D3C 7D3C 1 6 DBREF 7D3C E 1 6 PDB 7D3C 7D3C 1 6 SEQADV 7D3C ASP B 34 UNP A0A0D3MU4 ASN 3191 CONFLICT SEQADV 7D3C ASP A 34 UNP A0A0D3MU4 ASN 3191 CONFLICT SEQRES 1 B 306 SER GLY LEU VAL LYS MET SER HIS PRO SER GLY ASP VAL SEQRES 2 B 306 GLU ALA CYS MET VAL GLN VAL THR CYS GLY SER MET THR SEQRES 3 B 306 LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TRP CYS PRO SEQRES 4 B 306 ARG HIS VAL MET CYS PRO ALA ASP GLN LEU SER ASP PRO SEQRES 5 B 306 ASN TYR ASP ALA LEU LEU ILE SER MET THR ASN HIS SER SEQRES 6 B 306 PHE SER VAL GLN LYS HIS ILE GLY ALA PRO ALA ASN LEU SEQRES 7 B 306 ARG VAL VAL GLY HIS ALA MET GLN GLY THR LEU LEU LYS SEQRES 8 B 306 LEU THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR SEQRES 9 B 306 THR PHE THR THR VAL LYS PRO GLY ALA ALA PHE SER VAL SEQRES 10 B 306 LEU ALA CYS TYR ASN GLY ARG PRO THR GLY THR PHE THR SEQRES 11 B 306 VAL VAL MET ARG PRO ASN TYR THR ILE LYS GLY SER PHE SEQRES 12 B 306 LEU CYS GLY SER CYS GLY SER VAL GLY TYR THR LYS GLU SEQRES 13 B 306 GLY SER VAL ILE ASN PHE CYS TYR MET HIS GLN MET GLU SEQRES 14 B 306 LEU ALA ASN GLY THR HIS THR GLY SER ALA PHE ASP GLY SEQRES 15 B 306 THR MET TYR GLY ALA PHE MET ASP LYS GLN VAL HIS GLN SEQRES 16 B 306 VAL GLN LEU THR ASP LYS TYR CYS SER VAL ASN VAL VAL SEQRES 17 B 306 ALA TRP LEU TYR ALA ALA ILE LEU ASN GLY CYS ALA TRP SEQRES 18 B 306 PHE VAL LYS PRO ASN ARG THR SER VAL VAL SER PHE ASN SEQRES 19 B 306 GLU TRP ALA LEU ALA ASN GLN PHE THR GLU PHE VAL GLY SEQRES 20 B 306 THR GLN SER VAL ASP MET LEU ALA VAL LYS THR GLY VAL SEQRES 21 B 306 ALA ILE GLU GLN LEU LEU TYR ALA ILE GLN GLN LEU TYR SEQRES 22 B 306 THR GLY PHE GLN GLY LYS GLN ILE LEU GLY SER THR MET SEQRES 23 B 306 LEU GLU ASP GLU PHE THR PRO GLU ASP VAL ASN MET GLN SEQRES 24 B 306 ILE MET GLY VAL VAL MET GLN SEQRES 1 A 306 SER GLY LEU VAL LYS MET SER HIS PRO SER GLY ASP VAL SEQRES 2 A 306 GLU ALA CYS MET VAL GLN VAL THR CYS GLY SER MET THR SEQRES 3 A 306 LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TRP CYS PRO SEQRES 4 A 306 ARG HIS VAL MET CYS PRO ALA ASP GLN LEU SER ASP PRO SEQRES 5 A 306 ASN TYR ASP ALA LEU LEU ILE SER MET THR ASN HIS SER SEQRES 6 A 306 PHE SER VAL GLN LYS HIS ILE GLY ALA PRO ALA ASN LEU SEQRES 7 A 306 ARG VAL VAL GLY HIS ALA MET GLN GLY THR LEU LEU LYS SEQRES 8 A 306 LEU THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR SEQRES 9 A 306 THR PHE THR THR VAL LYS PRO GLY ALA ALA PHE SER VAL SEQRES 10 A 306 LEU ALA CYS TYR ASN GLY ARG PRO THR GLY THR PHE THR SEQRES 11 A 306 VAL VAL MET ARG PRO ASN TYR THR ILE LYS GLY SER PHE SEQRES 12 A 306 LEU CYS GLY SER CYS GLY SER VAL GLY TYR THR LYS GLU SEQRES 13 A 306 GLY SER VAL ILE ASN PHE CYS TYR MET HIS GLN MET GLU SEQRES 14 A 306 LEU ALA ASN GLY THR HIS THR GLY SER ALA PHE ASP GLY SEQRES 15 A 306 THR MET TYR GLY ALA PHE MET ASP LYS GLN VAL HIS GLN SEQRES 16 A 306 VAL GLN LEU THR ASP LYS TYR CYS SER VAL ASN VAL VAL SEQRES 17 A 306 ALA TRP LEU TYR ALA ALA ILE LEU ASN GLY CYS ALA TRP SEQRES 18 A 306 PHE VAL LYS PRO ASN ARG THR SER VAL VAL SER PHE ASN SEQRES 19 A 306 GLU TRP ALA LEU ALA ASN GLN PHE THR GLU PHE VAL GLY SEQRES 20 A 306 THR GLN SER VAL ASP MET LEU ALA VAL LYS THR GLY VAL SEQRES 21 A 306 ALA ILE GLU GLN LEU LEU TYR ALA ILE GLN GLN LEU TYR SEQRES 22 A 306 THR GLY PHE GLN GLY LYS GLN ILE LEU GLY SER THR MET SEQRES 23 A 306 LEU GLU ASP GLU PHE THR PRO GLU ASP VAL ASN MET GLN SEQRES 24 A 306 ILE MET GLY VAL VAL MET GLN SEQRES 1 C 6 02J ALA VAL LEU PJE 010 SEQRES 1 E 6 02J ALA VAL LEU PJE 010 HET 02J C 1 8 HET PJE C 5 13 HET 010 C 6 8 HET 02J E 1 8 HET PJE E 5 13 HET 010 E 6 8 HETNAM 02J 5-METHYL-1,2-OXAZOLE-3-CARBOXYLIC ACID HETNAM PJE (E,4S)-4-AZANYL-5-[(3S)-2-OXIDANYLIDENEPYRROLIDIN-3- HETNAM 2 PJE YL]PENT-2-ENOIC ACID HETNAM 010 PHENYLMETHANOL FORMUL 3 02J 2(C5 H5 N O3) FORMUL 3 PJE 2(C9 H14 N2 O3) FORMUL 3 010 2(C7 H8 O) FORMUL 5 HOH *255(H2 O) HELIX 1 AA1 SER B 10 ALA B 15 1 6 HELIX 2 AA2 HIS B 41 MET B 43 5 3 HELIX 3 AA3 PRO B 45 LEU B 49 5 5 HELIX 4 AA4 ASN B 53 MET B 61 1 9 HELIX 5 AA5 THR B 62 HIS B 64 5 3 HELIX 6 AA6 CYS B 203 ASN B 217 1 15 HELIX 7 AA7 SER B 229 ASN B 240 1 12 HELIX 8 AA8 THR B 248 GLY B 259 1 12 HELIX 9 AA9 ALA B 261 GLY B 275 1 15 HELIX 10 AB1 THR B 292 MET B 301 1 10 HELIX 11 AB2 SER A 10 ALA A 15 1 6 HELIX 12 AB3 HIS A 41 CYS A 44 5 4 HELIX 13 AB4 PRO A 45 LEU A 49 5 5 HELIX 14 AB5 ASN A 53 MET A 61 1 9 HELIX 15 AB6 THR A 62 HIS A 64 5 3 HELIX 16 AB7 MET A 184 PHE A 188 5 5 HELIX 17 AB8 CYS A 203 ASN A 217 1 15 HELIX 18 AB9 SER A 229 LEU A 238 1 10 HELIX 19 AC1 THR A 248 GLY A 259 1 12 HELIX 20 AC2 ALA A 261 TYR A 273 1 13 HELIX 21 AC3 THR A 292 MET A 301 1 10 SHEET 1 AA1 7 ASN B 77 LEU B 78 0 SHEET 2 AA1 7 PHE B 66 GLN B 69 -1 N VAL B 68 O LEU B 78 SHEET 3 AA1 7 MET B 17 CYS B 22 -1 N GLN B 19 O GLN B 69 SHEET 4 AA1 7 MET B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 AA1 7 THR B 35 PRO B 39 -1 O THR B 35 N LEU B 32 SHEET 6 AA1 7 LEU B 89 VAL B 94 -1 O LEU B 90 N CYS B 38 SHEET 7 AA1 7 VAL B 80 GLN B 86 -1 N VAL B 81 O THR B 93 SHEET 1 AA2 5 TYR B 104 PHE B 106 0 SHEET 2 AA2 5 VAL B 159 ALA B 171 1 O PHE B 162 N THR B 105 SHEET 3 AA2 5 VAL B 151 GLU B 156 -1 N GLY B 152 O TYR B 164 SHEET 4 AA2 5 ALA B 114 TYR B 121 -1 N LEU B 118 O VAL B 151 SHEET 5 AA2 5 ARG B 124 VAL B 132 -1 O PHE B 129 N VAL B 117 SHEET 1 AA3 3 TYR B 104 PHE B 106 0 SHEET 2 AA3 3 VAL B 159 ALA B 171 1 O PHE B 162 N THR B 105 SHEET 3 AA3 3 THR B 174 SER B 178 -1 O THR B 174 N ALA B 171 SHEET 1 AA4 6 PHE A 66 GLN A 69 0 SHEET 2 AA4 6 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 3 AA4 6 MET A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 4 AA4 6 THR A 35 PRO A 39 -1 O TRP A 37 N LEU A 30 SHEET 5 AA4 6 LEU A 89 VAL A 94 -1 O LEU A 90 N CYS A 38 SHEET 6 AA4 6 VAL A 80 GLN A 86 -1 N GLN A 86 O LEU A 89 SHEET 1 AA5 5 TYR A 104 PHE A 106 0 SHEET 2 AA5 5 VAL A 159 ALA A 171 1 O PHE A 162 N THR A 105 SHEET 3 AA5 5 VAL A 151 GLU A 156 -1 N GLU A 156 O VAL A 159 SHEET 4 AA5 5 ALA A 114 TYR A 121 -1 N LEU A 118 O VAL A 151 SHEET 5 AA5 5 ARG A 124 VAL A 132 -1 O THR A 126 N ALA A 119 SHEET 1 AA6 3 TYR A 104 PHE A 106 0 SHEET 2 AA6 3 VAL A 159 ALA A 171 1 O PHE A 162 N THR A 105 SHEET 3 AA6 3 THR A 174 SER A 178 -1 O THR A 176 N MET A 168 LINK C 02J C 1 N ALA C 2 1555 1555 1.45 LINK C LEU C 4 N PJE C 5 1555 1555 1.45 LINK C PJE C 5 O 010 C 6 1555 1555 1.39 LINK C 02J E 1 N ALA E 2 1555 1555 1.45 LINK C LEU E 4 N PJE E 5 1555 1555 1.47 LINK C PJE E 5 O 010 E 6 1555 1555 1.40 CISPEP 1 LEU B 282 GLY B 283 0 -29.39 CISPEP 2 GLY B 302 VAL B 303 0 -20.41 CRYST1 79.620 93.223 103.015 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012560 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010727 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009707 0.00000